How Many Days Should I Take Antibiotics After an Implant? Can I Stop Them Myself?

How Many Days Should I Take Antibiotics After an Implant? Can I Stop Them Myself?

Direct answer: The clinician who prescribed your medicine decides its duration. This site does not give drug names, doses, or durations [F2]. Do not stop or change the amount on your own; if you have questions, ask the prescribing clinician or a pharmacist [F14][F15].

Scope: This guide is specific to Taiwan's healthcare system (National Health Insurance and Taiwan's Medical Care Act). The law and competent-authority health-education sections cite Taiwan's Pharmaceutical Affairs Act, Taiwan's Medical Care Act, and public information from the Ministry of Health and Welfare Food and Drug Administration; the clinical-evidence sections cite international literature. The fact ledger marks the two separately. Taiwan's Medical Care Act is cited in its official English rendering: https://law.moj.gov.tw/ENG/LawClass/LawAll.aspx?pcode=L0020021

Why this card gives no duration, drug name, or dose

This is not evasion. Three independent reasons each require a knowledge site to stay silent.

First, this is prescription-medicine territory. Article 50, paragraph 1 of Taiwan's Pharmaceutical Affairs Act states: “Medicines requiring a physician's prescription shall not be dispensed or supplied without a physician's prescription.” [F1] In other words, the legal design places decisions about whether to use a medicine, which one, and for how long with the clinician, not a search result.

Second, a health-education site that writes about a medicine's efficacy can cross into drug advertising. Article 65 of Taiwan's Pharmaceutical Affairs Act provides that a person other than a drug business may not advertise drugs; Article 70 treats interviews, reports, or publicity whose content implies or alludes to medical efficacy as drug advertising [F2]. km is an industry-neutral knowledge layer, not a drug business. Its editorial policy is therefore to give no drug name, dose, duration, or administration method, and not reproduce another person's prescription [F23].

Third, even apart from law, there is no standard answer to copy. The next section shows that even systematic reviews cannot derive a conclusion about how many days to use from the available trials [F7]. If a number that the literature cannot answer appears as a certainty on a webpage, first ask what supports it.

What this card can offer instead is three things: what research actually knows, why your prescription may differ from someone else's, and what to ask the clinician after you receive it [F23].

Research also has no standard answer to “how many days?”

Start with current practice. A 2026 systematic review and meta-analysis collected dentist surveys, record studies, and registry data from 2010-01 through 2025-10, including 39 studies (7,266 dentists and 137,207 patients) [F3]. Its pooled estimate found routine antibiotic prescribing at 61.3%, with very high heterogeneity; prescribing for compromised cases rose with procedural complexity to 97.3%. Only 1% to 28% was guideline-concordant, with a declining trend over time, and the authors rated overall certainty as very low [F3].

Those figures mean that the number of days your friend took, or a number in an online article, reflects very different prescribing habits—not a standard duration [F3][F23].

Is duration itself studied? The current Cochrane systematic-review version (2013, searched to 2013-06-17, the current version in that review-number chain) included 6 randomized trials and 1,162 participants. Only one trial compared three prophylactic-antibiotic durations; none of the 25 people in each group had an implant or prosthesis failure, infection, or adverse event. The authors therefore could not derive conclusive information, and no trial compared different antibiotics or doses [F7]. Its conclusion also says it remains unknown whether postoperative continuation is beneficial and which antibiotic is more effective [F7].

In evidence terms, the “how many days” box is blank [F7]. Blank does not mean “anything goes”; it means only the person who knows your clinical situation can fill that box [F14][F23].

The reviews do not even point in the same direction

For the same clinical question, four reviews reach different directions—and that is itself important to know:

• 2013 Cochrane (6 trials; 1,162 participants): statistically significantly more implant failures occurred in groups not receiving antibiotics. The number needed to treat to prevent one implant failure was 25 (95% confidence interval 14 to 100), based on a 6% implant-failure rate among those not receiving antibiotics. Infection and adverse events did not show statistically significant differences [F7].
• 2021 systematic review and meta-analysis (11 studies): antibiotics significantly reduced early implant failure (risk ratio 0.30, 95% confidence interval 0.19 to 0.47). No difference was detected between preoperative dosing and preoperative plus postoperative dosing (risk ratio 0.57, 95% confidence interval 0.21 to 1.55) [F6].
• 2023 systematic review and meta-analysis (12 randomized trials): prevention of complications was not statistically significant (p = 0.96). The authors concluded that the benefit of routine prophylactic antibiotics did not justify routine use. That examines the policy of giving medicine to everyone; it does not say that your prescription is unnecessary and is not a reason to stop it yourself. They proposed a clinical assessment pathway based on age, oral and skeletal status, chronic disease, and smoking [F5].
• 2024 systematic review and meta-analysis (7 randomized trials, 1,859 patients, 3,014 implants): no statistically significant difference in patient-level early implant failure was detected (risk ratio 0.66, 95% confidence interval 0.30 to 1.47). The risk difference was -0.007 and the number needed to treat was 143; the authors concluded that findings did not support routine prophylactic antibiotics [F4]. Again, that is a policy-level conclusion about prescribing to everyone, not a judgment on your individual prescription or a basis for stopping it yourself.

One reading detail matters: “no difference detected” means not detected, not proved absent. The 2021 confidence interval is 0.21 to 1.55 and the 2024 interval is 0.30 to 1.47. Both are wide and cross 1, so the studies lack power to exclude a difference in either direction [F4][F6]. Reading “not statistically significant” as “therefore no difference, so it can be skipped” is an easy mistake [F23].

The four reviews differ in inclusion criteria, years, and populations. This is not “who is right and who is wrong”; it is a question on which professional disagreement remains [F23]. When the field itself remains divided, a single online duration answer has no matching evidence base and cannot know your clinical situation.

What this is especially easy to misread

The statement above that no difference was detected between preoperative and preoperative-plus-postoperative dosing is one of this card's highest-risk sentences. It does not mean “you may stop the postoperative packets yourself” [F6][F23]. There are three reasons:

1. The studies compared how clinicians prescribe, not what patients may stop. Randomized trials assigned groups before surgery and followed the protocol throughout; no group was “patients changed their mind halfway through” [F6][F7].
2. They concerned routine implants in healthy patients and prophylaxis. If your medicine was prescribed because there is already an infection (treatment), or because of surgical extent, bone grafting, sinus-floor elevation, or systemic disease, conclusions from prophylaxis studies do not apply [F8][F9][F19].
3. Certainty is generally low. The 2026 review rated overall certainty very low [F3], and the 2025 umbrella review of sinus-floor elevation rated it low to very low [F9]. Using a low-certainty group conclusion to override a clinician's individual judgment reverses the direction of care [F23].

Why your prescription differs from another person's

The Cochrane review's background described the general outline of indications for surgical prophylactic antibiotics: generally only people at risk of infective endocarditis, with reduced host response, undergoing surgery at an infected site, having extensive and prolonged surgery, or receiving large foreign materials have indications [F10]. This is background description of general understanding at that time, not the review's result and not a rule for you [F10].

Sinus-floor elevation is closer to an implant context. A 2025 umbrella review (7 systematic reviews and meta-analyses) reported infection rates from 0.3% to 11.6% after sinus-floor elevation and implant survival consistently above 90% regardless of antibiotic regimen. Those are pooled research-level figures, not an individual success prediction. High- or moderate-quality reviews provided limited but consistent evidence that antibiotics may reduce infection risk in high-risk situations—membrane perforation, an extensive lateral approach, or systemic comorbidities—whereas routine use in uncomplicated sinus-floor elevation may not be necessary. The authors emphasized low to very low overall certainty and advised cautious interpretation [F9].

That is what “individualization” looks like. Although both are called implant treatment, bone grafting, sinus-floor elevation, membrane perforation, and chronic disease occupy different evidence boxes [F9][F10]. Comparing your medication bag with someone else's duration therefore compares two different things [F23].

You are entitled to ask for this to be explained. Article 81 of Taiwan's Medical Care Act requires a medical-care institution treating a patient to inform the patient or listed relevant person about condition, treatment policy, procedures, medication, prognosis, and possible adverse reactions [F11]. Medication and possible adverse reactions are already within what must be explained.

“Can I stop it myself?”: Taiwan authority guidance and the international debate

Current Taiwan competent-authority health-education position

The Ministry of Health and Welfare Food and Drug Administration's medication-safety information issued on 2025-07-23 sets out “Four Don'ts and One Do” [F14]:

• Do not proactively demand antibiotics—colds are usually viral and do not necessarily need antibiotics.
• Do not casually buy antibiotics for yourself—consult clinicians and pharmacists before using medicines.
• Do not take another person's antibiotics—people's constitution, illness, and physiological state differ.
• Do not casually stop the medicine—complete the course and do not stop it on your own, to avoid antimicrobial resistance.
• Do follow medical instructions for antibiotic use—confirm the reason, dose, frequency, and duration [F14].

The notice explains that misuse, an insufficient dose, or too short a course may leave bacteria that develop the ability to resist medicine—antimicrobial resistance [F14]. It also says that if a severe adverse drug reaction follows taking someone else's medicine, drug-injury relief cannot be applied for because the medicine was not used properly and lawfully [F14]. Case-specific determinations and applications are within the authority of the competent authority and the Drug Relief Foundation; this site gives no legal opinion [F23].

The original setting of that notice is medication safety for children's colds, not post-implant care [F14]. This card cites only the cross-context principles not to stop on one's own, not to take another person's medicine, not to buy it oneself, and to follow medical instructions; it does not transplant children's-cold care into dentistry [F23].

What is debated internationally

Put the conclusion first: this section is not a basis for stopping medicine yourself. After reading it, continue to use the prescription as directed and ask the prescribing clinician or pharmacist if unsure. Within that condition, one point should be stated honestly: international literature has questioned the public-health message that one must always finish a course or resistance will result. A 2017 BMJ analysis argued that the claim that stopping antibiotics early encourages resistance is not supported by evidence, while taking them longer than necessary increases resistance risk. It described then-current public information from the US Centers for Disease Control and Prevention and Public Health England as replacing “complete the course” with “exactly as prescribed” [F15].

That article is not permission for patients; it says the opposite. Its debate concerns how policy makers and clinicians should determine duration and communicate it. Its recommended replacement is “exactly as prescribed”: the decision remains with the prescriber, while emphasizing case-specific decisions rather than a universal call to “finish everything” [F15][F23].

Thus Taiwan authority guidance and that international debate meet at the same sentence: use it as the prescribing clinician directs. Before changing anything—stopping, reducing, extending, or switching—ask that clinician; do not decide for yourself or from an online article [F14][F15][F23].

Stopping on one's own is common; that is why this is widely searched

A 2026 Malaysian national online survey (1,031 respondents; upper respiratory infection and sore-throat setting) recorded unsafe behaviors including keeping leftover antibiotics in 34% and stopping treatment early in 45% [F16]. It is not dental, not Taiwan, and is a self-reported questionnaire, so it cannot estimate the proportion among Taiwan implant patients [F16]. This card uses it only to show that self-stopping is a commonly occurring behavior, not a rare exception [F23].

Risk factors: risks of antibiotics themselves and situations to watch

Antibiotics are not harmless “extra medicine.” That is also why a clinician, not a patient, decides whether to add or reduce them.

• Adverse reactions range widely. The Cochrane review background says antibiotics may cause adverse events from diarrhoea to life-threatening allergic reactions [F10]. The Food and Drug Administration lists possible related effects including rash, diarrhoea, and nausea or vomiting, and says to seek care immediately if an abnormal reaction occurs after antibiotics [F14].
• Allergic reactions truly exist in dental settings. A 2025 systematic review of mechanisms of allergic reactions related to dental care specifically considered immediate reactions mediated by immunoglobulin E and delayed reactions mediated by sensitised T lymphocytes [F17]. This card lists no sensitizing-medicine list—tell your clinician and pharmacist your own allergy history directly [F23].
• There are observed data on intestinal complications. In a US-veteran cohort, 108 people (0.05% of the cohort) developed Clostridioides difficile infection within 30 days after a dental antibiotic prescription. Of them, 80% received guideline-discordant antibiotics; half had chronic gastrointestinal illness that could worsen infection risk [F18]. The 30 days here are the study's observation window, not a recommendation for any medication duration [F23].
• Antimicrobial resistance is a population-level cost. The Cochrane background names selection of resistant bacteria from widespread antibiotic use as a major concern [F10]. A 2025 systematic review of third-molar extraction (20 randomized trials) also found no statistically significant difference in postoperative-complication proportions between treatment groups and no difference in antibiotic-related adverse events from placebo, while noting that allergy risk and possible resistance require careful, prudent antibiotic use; it found insufficient evidence to recommend routine prophylaxis for healthy young people having third-molar extraction [F19]. Its setting is wisdom-tooth extraction, not implants; this card does not extend its conclusion to implants [F19].
• Antibiotics are not insurance. A retrospective cohort (337 patients and 1,273 implants) defined postoperative infection as purulent drainage and/or increasing pain and swelling at the surgical site before prosthetic loading. It recorded 22 postoperative infections (6.5% of patients and 1.7% of implants), usually diagnosed within the first month; 17 (77.3%) underwent surgery because drug treatment failed [F20]. This shows two things: taking medicine does not mean infection cannot occur, and when infection does occur, the need is review and treatment—not self-increasing or extending medication [F20][F23].

Risk disclosure (necessary explanation for health education under Article 87 of Taiwan's Medical Care Act): Implant treatment is invasive surgery with risks and contraindications. Whether antibiotics are needed, which one, and for how long are prescription judgments requiring assessment of individual medical history, allergy history, surgical extent, and current clinical condition. Actual treatment and results vary by person and require a dentist's assessment [F11][F14].

Contact the prescribing clinician or seek care immediately in these situations

The following red flags come from competent-authority public information and literature definitions; they are not a self-diagnosis scale. If any applies, contact the prescribing institution or seek care; do not stop or change medicine yourself [F14][F23].

• The six early warning signs of drug allergy: rash, mouth sores, sore throat, red/swollen eyes, swollen lips, and fever. The Food and Drug Administration describes skin rash, oral ulceration, throat pain, red swollen eyes, swollen lips, and fever, and highlights abnormalities of mucosal sites such as the mouth, throat, or eyes [F13].
• Palpitations, difficulty breathing, marked unexplained fatigue, nausea, jaundice, or tea-coloured urine. The same information says these may also be drug-allergy symptoms and are signals to seek care immediately [F13].
• Any abnormal reaction after taking the medicine. Its antibiotic advice is to watch for rash, diarrhoea, or another abnormal reaction during use, and seek care immediately if one occurs [F14].
• Severe or persistent diarrhoea. Antibiotic-related intestinal complications have observed cases, and chronic gastrointestinal illness may raise risk [F10][F18].
• Pus at the surgical area, or pain and swelling that worsen instead of improve. This is the literature's operational definition of postoperative infection. Of its 22 recorded infections, 17 (77.3%) underwent surgery only after drug treatment failed [F20]. For the full pain-trajectory grading, see the implant-pain card [F21].

Drug-allergy symptoms may occur within days of taking medicine, or sometimes only after two to three months. The Food and Drug Administration advises keeping the prescription record during medication use, seeking care promptly when unwell and providing that record to healthcare staff; people with a past drug allergy may ask staff to record it on an allergy record card [F13].

Checklist before seeking care: 7 questions to ask after you receive the prescription

These 7 questions are this site's communication framework. They put “who should decide” back in the right place; they are questions to ask, not answers [F23].

1. Is this medicine for prevention, or for treatment because there is already an infection? The reasoning differs [F7][F10].
2. Did I have bone grafting or sinus-floor elevation this time? Was there membrane perforation? Does that change the medication judgment? [F9]
3. Until when should it be used, and what is the basis? Will it be reassessed at an interim visit? [F3][F11]
4. Could my allergy history and medicines I am currently taking (please read each one out) affect this? [F13][F17]
5. Which signs mean I should call immediately, rather than wait for the next visit? Which number should I use outside clinic hours? [F13][F14]
6. If I miss one dose, or swelling remains after finishing, what should I do and whom should I contact? [F14][F20]
7. How should remaining medicine be handled? May it be kept for a future use? [F14]

How to find a clinic that provides this service

This site lists no clinics and does not recommend, rate or compare any medical institution.

To find a clinic that provides this service, use the following official lookup channels yourself —

they are maintained by the competent authorities and are more current than any list:

>

- The Ministry of Health and Welfare's medical-institution lookup: search by city or county,

township and specialty (dentistry) for institutions that have completed practice registration.

The results show the institution's name, address and registered specialty. This is the first place

to confirm whether a clinic is lawfully registered.

- The National Health Insurance Administration's contracted-institution lookup: check whether a

clinic is under contract with National Health Insurance. This determines which items are covered

and which are self-paid, and therefore what kind of fee explanation you will be given.

>

Both systems are on the respective authorities' official websites; searching for the

medical-institution lookup or the contracted-institution lookup will find them. This site does not

reproduce the URLs, because they change; use whichever entry point the authority currently publishes.

>

In an emergency, do not spend time looking up lists. If your breathing, swallowing or speech is

affected, or swelling is spreading, go to the nearest emergency department.

Chinese labels to look for on the official pages

These official systems, datasets and files are published in Chinese only. The English names above are this site's renderings; on the page itself you will see the following strings, so search for these:

>

- 「醫事機構查詢」

- 「特約醫事機構查詢」

- 「特約院所查詢」

- 「藥事法§50-全國法規資料庫」

Compliance note

This is health education information under Article 87 of Taiwan's Medical Care Act, not medical advertising, and it does not recommend a particular institution. Implant treatment and antibiotic use have risks and contraindications; actual treatment and results vary by person and require a dentist's assessment. This article gives no medicine name, dose, duration, or administration method and is not medication instruction. Any start, adjustment, or stopping of medication must be decided by the prescribing clinician [F1][F2][F12]. Laws and competent-authority information cited here are the public content on the dates in the source list.

Every clinical statement in this article is mapped line by line to its cited source (see the sources and evidence chain below). It has not been clinically reviewed by a licensed practitioner. This is health information, not individual advice; assessment by a clinician is required.